What does Outlook Therapeutics, Inc. do?

Jun 22 2025 06:50 PM IST
share
Share Via
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing biosimilar therapeutics, particularly monoclonal antibodies, in immunology and oncology. It has a market cap of USD 72.42 million and reported a net profit loss of USD 46 million as of March 2025.
Overview:
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing biosimilar therapeutics, particularly monoclonal antibodies, in the immunology and oncology sectors. The company operates within the Pharmaceuticals & Biotechnology industry and has a market cap of USD 72.42 Million.

Financial Snapshot:
Most recent Net Profit: -46 Million (Quarterly Results - Mar 2025)
Market cap: USD 72.42 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.79
Return on Equity: 233.83%
Price to Book: -2.23

Contact Details:
Address: 4260 U.S. Route 1, MONMOUTH JUNCTION NJ : 08852
Tel: ['1 609 6193990', '1 212 9152568']
Website: http://oncobiologics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Outlook Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:27 PM IST
share
Share Via
Is Outlook Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:06 AM IST
share
Share Via
How big is Outlook Therapeutics, Inc.?
Jun 22 2025 06:06 PM IST
share
Share Via
Most Read
Why is Bluestone Jewel falling/rising?
1 hour ago
share
Share Via
Why is Borana Weaves falling/rising?
1 hour ago
share
Share Via
Why is Malpani Pipes falling/rising?
1 hour ago
share
Share Via
Why is Sat Kartar falling/rising?
1 hour ago
share
Share Via
Why is Baazar Style falling/rising?
1 hour ago
share
Share Via
Why is Blackbuck falling/rising?
1 hour ago
share
Share Via